Traws Pharma Inc
TRAW
$0.58+3.36%
End of day · as of Aug 26, 2026, 7:55 AM ET
Mkt cap
$12.10M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2025-09-30)
$2.79M
EPS (H1 2026)
$-0.64
Gross Margin (qtr ended 2025-09-30)
N/A
Profit Margin (qtr ended 2025-09-30)
595.45%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Use this TRAW research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full TRAW income, balance, and cash tables.
Traws Pharma Inc (TRAW) is a biotechnology company in the Healthcare sector.
Latest cached Traws Pharma Inc (TRAW) revenue for Sep 30, 2025 was $2.8M. Net income was $16.6M. Statements: https://lician.com/financials/traw
Traws Pharma Inc (TRAW) market capitalization is $12.1M on the latest cached snapshot.
Traws Pharma Inc (TRAW) cached previous close $0.56; day range $0.56 – $0.58; volume 53,986. Session quote: https://lician.com/quote/traw
Traws Pharma Inc (TRAW) latest cached earnings event is "TRAW earnings" on Aug 14, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TRAW filing is 8-K · Aug 14, 2026. Filings: https://lician.com/sec/traw